Delivery Order SPE2DB22D3019-SPE2DB25FK4AR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,135.42 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) on August 26, 2025, with completion targeted for August 27, 2025. The contract employs firm fixed price terms and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this procurement action....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Clomid 50 mg tablets (30-count) with a ceiling value of $4,422.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside provision was utilized for this procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,432.77 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,435.62 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,331.74 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This non-set-aside, competitively awarded contract with a firm fixed price structure is scheduled for completion by July 31, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This is a competitively awarded, non-set-aside firm fixed price delivery order valued at $4,370.26, with an ultimate completion date of August 22, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.18 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 10s. This competitively awarded, non-set-aside contract was finalized on April 22, 2025, with an ultimate completion date of April 23, 2025, and represents a firm fixed-price delivery order. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clomid 50 mg tablets in unit-dose packaging (30-count) under a firm fixed-price arrangement. The contract has a ceiling value of $4,717.22 and is scheduled for completion by September 15, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,137.71 delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 tablets. This is a firm fixed price, non-set-aside contract with a completion date of July 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4ARDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,919.07 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a pediatric pharmaceutical product commonly used in fertility treatment and endocrine management. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA's global pharmaceutical support program, AmerisourceBergen Drug Corp serves critical healthcare needs across military and federal healthcare systems, delivering a comprehensive range of brand-name and generic medications, vaccines, and medical supplies. The company's status as a child contract under this major vehicle demonstrates its established capacity to fulfill federal medical procurement requirements through competitive processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/5/25 |